The murine T-lymphoma cell line LBRM-33 is known to require synergistic signals delivered through the antigen receptor (T1-CD3) complex, together with interleukin 1 (IL-1), for activation of IL-2 gene expression and IL-2 production. Although 12-0-tetradecanoylphorbol-13-acetate (TPA) was capable of replacing IL-1 as an activating stimulus under certain conditions, biologic studies indicated that TPA failed to synergize with Ti-CD3-dependent stimuli under conditions in which IL-1 was clearly active. Acute exposure to TPA and other active phorbol esters resulted in a concentration-dependent inhibition of the increases in phosphoinositide hydrolysis and intracellular free Ca2+ concentration stimulated by phytohemagglutinin or anti-Ti antibodies. TPA treatment induced no direct alteration of phospholipase C enzymatic activities in LBRM-33 cells. In contrast, both T1-CD3 cross-linkage and TPA rapidly stimulated the phosphorylation of identical CD3 complex polypeptides, presumably via activation of protein kinase C. Exposure of LBRM-33 cells to TPA resulted in a time-dependent, partial down-regulation of surface T,-CD3 expression. Thus, TPA treatment inhibited the responsiveness of LBRM-33 cells to T1-CD3-dependent stimuli by inducing an early desensitization of Ti-CD3 receptors, followed by a decrease in membrane receptor expression. These studies indicate that phorbol esters deliver bidirectional signals that both inhibit T1-CD3-dependent phosphoinositide hydrolysis and augment IL-2 production in LBRM-33 cells.
Ti-CD3-dependent stimuli under conditions in which IL-1 was clearly active. Acute exposure to TPA and other active phorbol esters resulted in a concentration-dependent inhibition of the increases in phosphoinositide hydrolysis and intracellular free Ca2+ concentration stimulated by phytohemagglutinin or anti-Ti antibodies. TPA treatment induced no direct alteration of phospholipase C enzymatic activities in LBRM-33 cells. In contrast, both T1-CD3 cross-linkage and TPA rapidly stimulated the phosphorylation of identical CD3 complex polypeptides, presumably via activation of protein kinase C. Exposure of LBRM-33 cells to TPA resulted in a time-dependent, partial down-regulation of surface T,-CD3 expression. Thus, TPA treatment inhibited the responsiveness of LBRM-33 cells to T1-CD3-dependent stimuli by inducing an early desensitization of Ti-CD3 receptors, followed by a decrease in membrane receptor expression. These studies indicate that phorbol esters deliver bidirectional signals that both inhibit T1-CD3-dependent phosphoinositide hydrolysis and augment IL-2 production in LBRM-33 cells.
The T-cell antigen receptor is a multimeric structure consisting of a clonotypic, disulfide-linked heterodimer (Ti) noncovalently associated with a series of invariant transmembrane proteins collectively termed CD3 (40, 41) . Physiologic triggering of quiescent T cells occurs upon T1-CD3 binding of antigen plus major histocompatibility complex molecules on the surface of accessory cells (4) . Crosslinkage of surface T1-CD3 receptors by specific ligands (antigens, mitogens, anti-Ti-CD3 antibodies) initiates a sequence of transmembrane and intracellular events that transmit signals requisite for the activation of resting T cells (46) . Both the structural features and the close association of the CD3 polypeptides with the ligand-binding Ti heterodimer suggest that the CD3 complex is involved in signal transduction during Ti cross-linking.
The mechanism by which Ti-CD3 stimulation initiates transmission of regulatory signals across the T-cell plasma membrane remains undefined. However, certain biochemical consequences of Ti-CD3 cross-linking have been elucidated. Antigen receptor cross-linking induces rapid increases in the hydrolysis of membrane inositol phospholipids, particularly phosphatidylinositol-4,5-bisphosphate (PIP2) (46) . This hydrolytic reaction is catalyzed by a hormone-sensitive phospholipase C activity and gives rise to two molecules, inositol-1,4,5-trisphosphate and 1,2-diacylglycerol, known to stimulate mobilization of intracellular calcium ([Ca2+] i) and activation of protein kinase C (pkC), respectively (see references 1 and 7 for reviews). The tively) to bypass the ligand-receptor interactions normally required to stimulate resting T lymphocytes (5, 22) . Although phorbol ester treatment stimulates a diversity of cellular responses, these compounds also possess negative regulatory effects on certain cellular functions, including those of specific membrane receptors. Acute treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) strongly suppressed Ca2+ mobilization induced by fMet-Leu-Phe in the human leukemic cell line HL60 (25) , by carbachol in astrocytoma cells (36) , and by anti-immunoglobulin antibodies in B cells (32) . The results of these studies suggested that receptor desensitization was secondary to the pkC-mediated phosphorylation of a protein(s) critical to receptor-phospholipase C coupling. Receptor phosphorylation represents one major mechanism by which pkC activation could modulate receptor affinity, surface expression, or coupling to signal transduction systems (28) . Alternatively, in certain receptor systems, pkC-mediated protein phosphorylation appears to inhibit directly the function of a guanine nucleotide-binding (G) protein responsible for integrating receptor stimulation and phospholipase C activation (20, 36 (29) , directed against the £ subunit of the murine CD3 complex, was the gift of Jeffrey Bluestone, University of Chicago (Chicago, Ill.). Antibodies were prepared as concentrated serum-free culture supernatants generated by ultrafiltration through a 10,000-molecular-weight cutoff membrane (YM-10; Amicon Corp., Lexington, Mass.) and dialysis against phosphate-buffered saline.
Bioassays. LBRM-33 cells were stimulated for 4 or 24 h before collection of the conditioned medium for assay of IL-2 biologic activity, using the IL-2-dependent T-cell line HT-2 (45). Four-hour bioassays were performed in 48-well tissue culture plates containing 2 x 106 LBRM-33 cells per well in a final volume of 0.5 ml of complete medium. Twenty-four-hour bioassays were performed in 96-well plates containing 105 LBRM-33 cells per well in a final volume of 0.2 ml of complete medium. The assay for IL-2 biologic activity in LBRM-33 cell-conditioned supernatants has been described in detail elsewhere (3 (17) . The Ca2"-specific fluorescence of stirred, dye-loaded cell suspensions was measured as described elsewhere (2) .
Phospholipase C activities. Phospholipase C activities present in cytosolic extracts from LBRM-33 cells were assayed against both PI and PIP2 bilayer vesicles by a modification of previously described methods (24, 27 (47) . However, in a previous study (2) we observed that TPA provided a less effective second signal for IL-2 production than did IL-1 when PHA was present as the primary stimulus. The data presented in Fig. 1 describe this phenomenon in greater detail. Figure 1A provides representative results from 4-h culture experiments in which LBRM-33 cells were stimulated with 0.3% (vol/vol) PHA in the absence or presence of IL-1 and/or TPA. The IL-1 and TPA concentrations (10 U/ml and 30 nM, respectively) used in these studies each provided a maximal costimulatory signal in the assay (data not shown). Under these conditions, PHA alone stimulated no detectable IL-2 production, and TPA was completely inactive as a costimulus with PHA. In contrast, the combination of PHA plus IL-1 stimulated significant IL-2 release. These 4-h bioassays, therefore, demonstrate the marked difference between IL-1 and TPA in the provision of second signals for IL-2 production. Moreover, the combination of PHA, IL-1, and TPA stimulated higher levels of IL-2 production than were attainable with PHA plus IL-1. It is important to note that IL-1 plus TPA alone stimulated no IL-2 production at either 4 h (not shown) or 24 h (Fig. 1B) . The data presented in Fig. 1B provide representative results from a series of 24-h incubations with the same stimuli. With these longer incubation times, synergy between PHA and TPA was readily apparent, although IL-1 remained the more potent costimulus for IL-2 production. In three independent experiments, the IL-2 level in supernatants from PHA-plus-TPA-stimulated cells ranged from 40 to 65% of the level in supernatants from PHA-plus-IL-1-stimulated cultures (based on comparisons of supernatant dilutions required to produce a half-maximal proliferative response in the IL-2 bioassay). Simultaneous addition of PHA, IL-1, and TPA into LBRM-33 cell cultures consistently resulted in a partial suppression of IL-2 production relative to that observed with PHA plus IL-1 only.
Although T-cell activation initiated by PHA presumably results from cross-linkage of the Tj-CD3 complex (12), other T-cell surface structures react with PHA and may contribute to the activation response (12 TPA induced a concentration-dependent inhibition of inositol phosphate formation in LBRM-33 cells stimulated with either 0.3% PHA or KJ16-MAR18.5 complexes (Fig. 3) . In these experiments, the cells were exposed to TPA for less than 5 min before stimulation with PHA or KJ16-MAR18.5 complexes. The concentrations of TPA required to inhibit PHA-and KJ16-MAR18.5-dependent inositol phosphate release by 50% (IC50) were 2.8 and 0.7 nM, respectively. These IC50s approximate the binding constant of TPA for pkC in purified enzyme preparations (6) . The lower potency of TPA as an inhibitor of PHA relative to that of KJ16-MAR18.5-stimulated phosphoinositide hydrolysis suggests either that PHA represents a more efficient T1-CD3 receptor agonist or that PHA activates other phospholipase C-linked membrane receptors with lesser sensitivities to the uncoupling effects of TPA.
Effect of TPA homologs on phosphoinositide hydrolysis.
Like TPA, 4p-phorbol didecanoate (PDD) is known to activate pkC in LBRM-33 cells (2), albeit with lower potency in intact cells because of its greater hydrophobicity (11) . In contrast, the 4a-PDD isomer was virtually inactive in these earlier pkC translocation studies. 4a-PDD was correspondingly inactive, over a wide concentration range, as an inhibitor of PHA-stimulated inositol phosphate release in LBRM-33 cells (Fig. 4) . The pkC-activating isomer, 41B-PDD, was an effective inhibitor of this response, with an approximate IC50 of 3.9 nM. Therefore these results support the hypothesis that T1-CD3 receptor uncoupling by phorbol esters is mediated through activation of pkC in LBRM-33 cells.
Kinetics of TPA-mediated inhibition of specific phosphoinositide hydrolysis. The preceding experiments demonstrated that TPA blocks total inositol phosphate accumulation in LBRM-33 cells stimulated by Tj-CD3 receptor cross-linking.
However, 'P3 appears to represent the principal Ca2+-mobilizing second-messenger metabolite generated during receptor activation (7) . Therefore, TPA must inhibit specifically the hydrolysis of PIP2, and the concomitant formation cantly elevated within 1 min of addition of the stimulus (Fig.  5 ). Both inositol phosphate fractions exhibited maximal elevations after 10 min of stimulation. The addition of 1.6 nM TPA at the start of the incubation induced an immediate and persistent suppression of the stimulus-induced release of both 1P3 and 1P2 plus IP1. Thus, pkC activation by TPA very rapidly uncouples the Ti-CD3 complex from phospholipase C activation and PIP2 hydrolysis. Furthermore, these data do not support the possibility that TPA inhibits net IP3 formation by stimulation of 5'-phosphomonoesterase activity, as described in platelets (13), because TPA treatment also suppressed, rather than enhanced, receptor-dependent IP2-plus-IP1 production (Fig. SB) . Effect of TPA treatment on phospholipase C activities. Phospholipase C activity itself might be inhibited by a pkC-mediated phosphorylation event in TPA-treated LBRM-33 cells. In preliminary experiments (data not shown), we examined the subcellular distribution of phospholipase C activities in LBRM-33 cells. In LBRM-33 cells, all detectable phospholipase C activities were present in the high-speed supernatant prepared from cell sonic extracts, and we have obtained no evidence for G-protein modulation of these activities (data not shown). Subsequently, we examined the effects of various cellular pretreatments on the hydrolysis of [3H]PI and [3H]PIP2 bilayer vesicles by phospholipase C activities present in crude cytosolic extracts prepared from LBRM-33 cells (Fig. 8) . The phospholipase C-dependent hydrolysis of both substrates was shown to be Ca2+ dependent; therefore, free Ca2+ concentrations were optimized in EGTA-buffered medium to allow maximal hydrolysis of either PI or PIP2 vesicles by cytosolic extracts from untreated LBRM-33 cells. Under linear reaction conditions, phospholipase C activity against either PI (Fig. 8A) or PIP2 (Fig. 8B) Effect of TPA treatment on T-cell receptor phosphorylation. Phorbol ester exposure has been shown to induce the rapid phosphorylation of the CD3--y(gp2l) and CD3-e(p25) chains in T cells (31, 40, 41) . Because receptor phosphorylation has been shown to regulate both receptor function and internalization rate (28, 31) , we examined the effect of TPA on the phosphorylation states of CD3 polypeptides expressed by LBRM-33 cells. The cells were labeled with 32Pi, stimulated with various agonists, and immunoprecipitated with a cocktail of F23.1 (anti-Ti heterodimer) and 145-2C11 (anti-CD3-e) monoclonal antibodies. No basal phosphorylation of CD3 polypeptides was detected in immunoprecipitates from unstimulated LBRM-33 cells (Fig. 9A) . Stimulation with 0.3% PHA for 10 min (Fig. 9B) induced detectable but relatively low-level phosphorylations of acidic polypeptides with molecular weights identical to those reported for the CD3--y and -e chains (40) . TPA (4.8 nM) alone induced a series of phosphorylation events involving both CD3-y and CD3-e polypeptides (Fig. 9C) . The TPA effect was concentration dependent, with maximal phosphorylation observed at a concentration of 30 nM (data not shown). The resolution of three separate 21-kilodalton phosphoproteins in the first (NEPHGE) dimension reflects the variable sialylation of the y chain (40, 41) . The relatively basic phosphoprotein observed at a slightly lower molecular weight than that of this y-chain series appears to represent either an intracellular precursor or a partial proteolytic product of the y polypeptide. Costimulation of LBRM-33 cells with 0.3% PHA and 4.8 nM TPA yielded an identical phosphorylation pattern; however, the combined stimuli consistently induced a higher level of CD3 phosphorylation than was observed with either stimulus alone (Fig. 9D) . Therefore, TPA concentrations that inhibit Ti-CD3-dependent transmembrane signaling concomitantly enhance the pkC-dependent phosphorylation of CD3 polypeptides in LBRM-33 cells. It is generally believed that these early biochemical events provide the requisite signals for T-cell activation and lymphokine production, in part on the basis of the synergistic effects of Ca2" ionophores and phorbol esters as receptorindependent stimuli for these T-cell responses (5) . In fact, TPA has been extensively used in T-cell activation studies as a replacement for accessory cell-derived second signals, including IL-1. In this study, we report findings consistent 2 (33) implicates either a G protein or phospholipase C itself as a relevant pkC substrate in this system. In contrast, TPA alters the smooth-muscle response to nonepinephrine by stimulating phosphorylation of the a1-adrenergic receptor, which results in a decrease in receptor affinity for ligand (28) . From these studies and others (25, 35, 36) The molecular mechanism by which the Tj-CD3 receptor is coupled to phospholipase C in T cells is currently undefined. Indirect evidence for the presence of a pertussis toxin-insensitive G protein in the T-cell plasma membrane was provided by recent studies using a human T-cell leukemia line, Jurkat (21, 42) , and a murine T-cell hybridoma (37) as model systems. elevations by TPA provides an explanation for the failure of TPA to synergize with PHA at 4 h (Fig. 1A) and with the anti-Ti antibodies even after 24 h (Fig. 1C) in the absence of IL-1. PHA alone can synergize with TPA; however, much longer periods of cellular stimulation are required. Taken together, these results strongly suggest that T,-CD3 stimulation delivers both Ca2+-dependent and -independent signals for IL-2 production. The former signaling pathway is mediated through phospholipase C activation and is susceptible to inhibition by TPA, whereas the latter signaling pathway is initiated by an unknown mechanism and is insensitive to TPA. Indeed, TPA itself may trigger biochemical events by mechanisms distinct from pkC activation. Gelfand and coworkers (14) first described the ability of TPA to stimulate a Ca2'-independent proliferative response in mitogen-acti- (34) , or fixed antigen-presenting cells (23) . Further studies of the mechanisms of Tj-CD3 complex desensitization will, therefore, not only increase our understanding of the molecular mechanisms and regulation of T1-CD3-dependent signal transduction but also help elucidate the biochemical events that modulate T-cell responses to antigenic stimulation in vivo.
